Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.443
+0.063 (16.58%)
Dec 26, 2024, 4:00 PM EST

Telesis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
11235317--
Market Cap Growth
-78.20%-66.23%-88.81%---
Enterprise Value
44497222--
Last Close Price
0.427.1821.60194.40--
PS Ratio
0.040.431.2928.66--
PB Ratio
1.750.410.763.49--
P/TBV Ratio
--1.194.27--
EV/Sales Ratio
2.561.790.2620.13--
Debt / Equity Ratio
4.211.160.460.190.620.15
Asset Turnover
0.260.360.280.150.20-
Inventory Turnover
3.373.395.184.544.50-
Quick Ratio
0.873.073.668.882.8017.79
Current Ratio
1.233.714.089.573.0518.25
Return on Equity (ROE)
-178.99%-125.42%-70.58%-74.75%-80.28%-
Return on Assets (ROA)
-30.10%-28.95%-29.40%-30.63%-31.16%-
Return on Capital (ROIC)
-33.51%-33.31%-33.00%-33.75%-35.29%-
Earnings Yield
-6593.67%-398.91%-136.82%-12.31%--
FCF Yield
-3162.03%-306.32%-121.90%-12.18%--
Buyback Yield / Dilution
-3.53%-1.31%-61.69%-264.34%-0.03%-
Total Shareholder Return
-3.53%-1.31%-61.69%-264.34%-0.03%-
Source: S&P Capital IQ. Standard template. Financial Sources.